| Filed On | Filing |
|---|---|
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
Investors: Shawn Bevec, SVP, Investor Relations - [email protected] |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
Investors: Shawn Bevec, SVP, Investor Relations - [email protected] |
| 22 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
FRANKLIN LAKES, N.J. (July 22, 2026) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Michael (Mike) Garrison has informed the company of his intent to retire after m... |
| 29 May 2026 |
8-K: Regulation FD Disclosure
As previously disclosed, on May 6, 2026, Becton, Dickinson and Company ("BD") voluntarily placed ChloraPrep™ and PurPrep™ on ship hold in the U.S. while it conducted additional final release testing. After completion of additional assess... |
| 20 May 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
SIXTH SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of May 20, 2026, among Becton Dickinson Euro Finance S.à r.l., a private limited liability company (société à responsabilité limitée) incorporated under the laws of t... |
| 12 May 2026 |
8-K: Other Events
World Trade Center, Tower Two, 5th Floor, Strawinskylaan 1887 |
| 07 May 2026 |
8-K: Results of Operations and Financial Condition
Investors: Shawn Bevec, SVP, Investor Relations - [email protected] |
| 29 Apr 2026 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
The registered office of Becton, Dickinson and Company (the “Company”) shall be in the Borough of Franklin Lakes, County of Bergen, State of New Jersey or such other place within or without the State of New Jersey as the Board of Directo... |
| 09 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
FRANKLIN LAKES, N.J. (April 9, 2026) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Richard (Rick) Byrd has informed the company of his intent to retire after nearly 25... |
| 02 Apr 2026 |
8-K: Results of Operations and Financial Condition
The unaudited financial information included herein contains certain financial measures that differ from those presented in accordance with generally accepted accounting principles in the United States ("non-GAAP measures"). These non-GA... |
| 25 Feb 2026 |
8-K: Other Events
FRANKLIN LAKES, NJ, February 25, 2026 – BD (Becton, Dickinson and Company) (NYSE: BDX) (the “Company” or “BD”), a leading global medical technology company, today announced the consideration payable in connection with its previously anno... |
| 10 Feb 2026 |
8-K: Other Events
FRANKLIN LAKES, NJ, February 10, 2026 – BD (Becton, Dickinson and Company) (NYSE: BDX) (the “Company” or “BD”), a leading global medical technology company, today announced that it has commenced tender offers to purchase for cash the deb... |
| 09 Feb 2026 |
8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +2 more
This TAX MATTERS AGREEMENT (this “Agreement”) is entered into by and among Becton, Dickinson and Company, a New Jersey corporation (the “Company”), Augusta SpinCo Corporation, a Delaware corporation (“SpinCo,” and together with the Compa... |
| 09 Feb 2026 |
8-K: Results of Operations and Financial Condition
Investors: Shawn Bevec, SVP, Investor Relations - [email protected] |
| 05 Feb 2026 |
8-K: Unregistered Sales of Equity Securities; Amendments to Articles/Bylaws; Change in Fiscal Year
The undersigned Corporation, for the purpose of amending its Restated Certificate of Incorporation, dated as of January 30, 2019 (the “2019 Restated Certificate of Incorporation”), as amended by the Certificate of Amendment dated as of M... |
| 05 Feb 2026 |
8-K: Regulation FD Disclosure
These revenue schedules include adjusted revenues and revenue growth rates on a currency-neutral, adjusted and organic basis. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the Un... |
| 30 Jan 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
The purpose of the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan is to provide an incentive to employees of the Company and its subsidiaries to achieve long-range goals, to aid in attracting and ... |
| 06 Jan 2026 |
8-K: Temporary Suspension of Trading Under Employee Benefit Plans
Temporary Suspension of Trading Under Registrant’s Employee Benefits Plans. |
| 17 Nov 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
On November 17, 2025, Robert L. Huffines and Jacqueline Wright were elected to the Board of Directors (the “Board”) of Becton, Dickinson and Company (“BD”), effective December 1, 2025. At that time, the size of the Board will expand from... |
| 06 Nov 2025 |
8-K: Results of Operations and Financial Condition
Investors: Adam Reiffe, VP, Investor Relations - 201-847-6927 |
Loading...